BrainsWay Closes $5 Million Convertible Loan to Neurolief

MT Newswires Live
2025/08/21

BrainsWay (BWAY) said Thursday it has closed a $5 million convertible loan to Neurolief, developer of a wearable brain neuromodulation platform for at-home use.

The agreement includes milestone-based funding of an additional up to $6 million convertible loan upon US Food and Drug Administration approval of Proliv Rx device for major depressive disorder, and up to $5 million equity investment linked to revenue milestones, BrainsWay said.

BrainsWay said it also received a call option to acquire all of Neurolief's equity at a price linked to enterprise value or a revenue multiple.

Shares of BrainsWay were up more than 4% in recent premarket activity Thursday.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10